New Haven Pharmaceuticals
Guilford
About New Haven Pharmaceuticals
New Haven Pharmaceuticals (NHP) is a specialty pharmaceuticals company developing proprietary prescription pharmaceuticals that utilize currently marketed drugs or generally recognized as safe (GRAS) active pharmaceutical ingredients (APIs) for use in therapeutic applications that represent significant market opportunities. The company's novel product pipeline employs proprietary, oral, controlled-release technologies, as well as intellectual property licensed from Yale University, which will enable optimal dosing, safety, efficacy and patient convenience.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $27.2M
- Funding stage: Early Stage Venture
- Last round: Debt Financing (Aug 2016)
- Website: newhavenpharma.com
- Phone: (770) 329-0074
Industries & Categories
Biotechnology, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/new-haven-pharmaceuticals-2217502 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.